Recital 23, Decision_act (EU) 2022/1006

In forcesince 24 Jun 2022

Having regard to the foregoing considerations, the Commission considers that risk mitigation measures to address the risk of primary and secondary poisoning incidents from the use of products containing alphachloralose should, exceptionally, pending the conclusion of the evaluation of alphachloralose, depend on the particular circumstances and available evidence of the occurrence of secondary poisoning incidents in the individual Member States. Some Member States might, for example, consider it necessary to restrict use to trained professionals while others might consider that additional labelling requirements suffice.